Login / Signup

Survival risk score for real-life relapsed/refractory chronic lymphocytic leukemia patients receiving ibrutinib. A campus CLL study.

Massimo GentileFortunato MorabitoGiovanni Del PoetaFrancesca Romana MauroGianluigi RedaPaolo SportolettiLuca LaurentiMarta CosciaYair HerishanuAnna Grazia RecchiaMarzia VarettoniRoberta MurruAnnalisa ChiarenzaAdalgisa CondoluciRiccardo MoiaDaniela PietrasantaGiacomo LosetoUgo ConsoliIlaria ScortechiniFrancesca Maria RossiAntonella ZucchettoVincenzo FraticelliErnesto VignaCirino BottaGiovanni TripepiGraziella D' ArrigoAngela RagoIlaria AngelettiAnnalisa BiagiIlaria Del GiudiceRiccardo BombenGian Matteo RigolinDavide RossiFrancesco Di RaimondoGianluca GaidanoAaron PolliackAntonio CuneoRobin FoàValter Gattei
Published in: Leukemia (2020)
Keyphrases
  • chronic lymphocytic leukemia
  • acute lymphoblastic leukemia
  • acute myeloid leukemia
  • multiple myeloma
  • hodgkin lymphoma
  • free survival